- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02902458
Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study (PEACE)
September 12, 2016 updated by: Centre Hospitalier Universitaire de Besancon
This study aims to investigate whether follow-up with a psychologist has an impact on the outcome of patients with an implantable automated defibrillator.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The implantation of an ICD in primary prevention is known to increase the rates of anxiety and depression, which can reach up to 45% and 35% respectively in this patient population.
Several studies have reported that psychological accompaniment for these patients can alleviate the symptoms of anxiety and/or depression.
Therefore, we aim to investigate the utility of psychological follow-up for a period of 1 year after first implantation of an ICD for primary prevention.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Besancon, France, 25000
- CHU Besançon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult patients (aged 18 years or over)
- indication for implantation of an ICD for primary prophylaxis
- written informed consent provided
- patients with social security coverage
Exclusion Criteria:
- patients under legal tutorship or guardianship
- patients with no social security coverage
- patients still within the exclusion period after participation in another clinical trial, as indicated by the national registry of clinical trial volunteers
- patients unable to complete the questionnaires (language barriers, mentally deficient, illiteracy or dementia)
- patients awaiting heart transplant
- patients who refuse to provide written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Psychological follow-up
Patients undergoing implantation of an ICD for primary prevention will have an individual interview with a qualified psychologist in addition to standard medical follow-up.
|
Individual, recorded interview with a qualified psychologist to discuss any and all subjects related to the ICD implantation, or any other topics deemed relevant by the patient.
|
|
No Intervention: Control
Patients undergoing implantation of an ICD for primary prevention will have standard medical follow-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mini International Neuropsychiatric Interview score
Time Frame: 48 hours after implantation
|
48 hours after implantation
|
|
Mini International Neuropsychiatric Interview score
Time Frame: 2 weeks after implantation
|
2 weeks after implantation
|
|
Mini International Neuropsychiatric Interview score
Time Frame: 2 months after implantation
|
2 months after implantation
|
|
Mini International Neuropsychiatric Interview score
Time Frame: 4 months after implantation
|
4 months after implantation
|
|
Mini International Neuropsychiatric Interview score
Time Frame: 6 months after implantation
|
6 months after implantation
|
|
Mini International Neuropsychiatric Interview score
Time Frame: 12 months after implantation
|
12 months after implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: 48 hours after implantation
|
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
|
48 hours after implantation
|
|
Quality of life
Time Frame: 2 weeks after implantation
|
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
|
2 weeks after implantation
|
|
Quality of life
Time Frame: 2 months after implantation
|
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
|
2 months after implantation
|
|
Quality of life
Time Frame: 4 months after implantation
|
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
|
4 months after implantation
|
|
Quality of life
Time Frame: 6 months after implantation
|
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
|
6 months after implantation
|
|
Quality of life
Time Frame: 12 months after implantation
|
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
|
12 months after implantation
|
|
State-Trait Anxiety Inventory
Time Frame: 48 hours after implantation
|
Measure of state and trait anxiety
|
48 hours after implantation
|
|
State-Trait Anxiety Inventory
Time Frame: 2 weeks after implantation
|
Measure of state and trait anxiety
|
2 weeks after implantation
|
|
State-Trait Anxiety Inventory
Time Frame: 2 months after implantation
|
Measure of state and trait anxiety
|
2 months after implantation
|
|
State-Trait Anxiety Inventory
Time Frame: 4 months after implantation
|
Measure of state and trait anxiety
|
4 months after implantation
|
|
State-Trait Anxiety Inventory
Time Frame: 6 months after implantation
|
Measure of state and trait anxiety
|
6 months after implantation
|
|
State-Trait Anxiety Inventory
Time Frame: 12 months after implantation
|
Measure of state and trait anxiety
|
12 months after implantation
|
|
Minnesota Living with Heart Failure questionnaire
Time Frame: 48 hours after implantation
|
Evaluation of the quality of life in patients with heart failure
|
48 hours after implantation
|
|
Minnesota Living with Heart Failure questionnaire
Time Frame: 2 weeks after implantation
|
Evaluation of the quality of life in patients with heart failure
|
2 weeks after implantation
|
|
Minnesota Living with Heart Failure questionnaire
Time Frame: 2 months after implantation
|
Evaluation of the quality of life in patients with heart failure
|
2 months after implantation
|
|
Minnesota Living with Heart Failure questionnaire
Time Frame: 4 months after implantation
|
Evaluation of the quality of life in patients with heart failure
|
4 months after implantation
|
|
Minnesota Living with Heart Failure questionnaire
Time Frame: 6 months after implantation
|
Evaluation of the quality of life in patients with heart failure
|
6 months after implantation
|
|
Minnesota Living with Heart Failure questionnaire
Time Frame: 12 months after implantation
|
Evaluation of the quality of life in patients with heart failure
|
12 months after implantation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Alexandre Guignier, MD, Centre Hospitalier Universitaire de Besancon
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
September 1, 2016
First Submitted That Met QC Criteria
September 12, 2016
First Posted (Estimate)
September 15, 2016
Study Record Updates
Last Update Posted (Estimate)
September 15, 2016
Last Update Submitted That Met QC Criteria
September 12, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P/2014/217
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implantable Defibrillator User
-
Paris Cardiovascular Research Center (Inserm U970)Hôpital Necker-Enfants MaladesCompletedImplantable Defibrillator User | Implantable Cardioverter Defibrillator Complications
-
Universitätsklinikum KölnRecruiting
-
Beth Israel Deaconess Medical CenterUniversity of Colorado, Denver; Mayo Clinic; University of Pennsylvania; Emory... and other collaboratorsEnrolling by invitationImplantable Defibrillator UserUnited States
-
Larisa TereshchenkoCompletedImplantable Defibrillator UserUnited States
-
Abbott Medical DevicesCompletedImplantable Defibrillator UserHungary, United States, Poland, Spain, United Kingdom
-
Biotronik, Inc.Terminated
-
Gulf Heart AssociationBoston Scientific Corporation; MedtronicCompletedImplantable Defibrillator UserUnited Arab Emirates
-
Universitätsklinikum KölnRecruitingImplantable Defibrillator User | Implantable Defibrillator Lead Dysfunction | Implantable Automatic Defibrillator MalfunctionGermany
-
Beth Israel Deaconess Medical CenterPatient-Centered Outcomes Research InstituteRecruitingPacemaker DDD | Implantable Defibrillator UserUnited States
Clinical Trials on Individual interview with a qualified psychologist
-
University Hospital, MontpellierUniversité MontpellierCompleted
-
University Hospital, MontpellierHospices Civils de Lyon; University Hospital, Strasbourg, France; Central Hospital... and other collaboratorsUnknown
-
Centre Hospitalier Universitaire DijonCompletedDevelopment DisordersFrance
-
Centre Hospitalier de ValenciennesCentre Oscar Lambret; Ligue contre le cancer, France; Hôpital Saint Vincent de... and other collaboratorsRecruiting
-
University Hospital, MontpellierCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Hospices Civils de LyonRecruiting
-
CAMC Health SystemCompletedVocal Cord DysfunctionUnited States
-
Institut de Cancérologie de la LoireHospices Civils de LyonCompleted
-
University Hospital, ToulouseCompletedIndolent Systemic Mastocytosis | Cutaneous MastocytosisFrance